A randomized, double-blind and placebo-controlled Phase II clinical trial of trigriluzole in patients with mild-to-moderate Alzheimer's Disease
Phase of Trial: Phase II
Latest Information Update: 15 May 2018
At a glance
- Drugs Trigriluzole (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 15 May 2018 According to a Biohaven Pharmaceutical Holding Company media release, study will initiate in Q2 2018.
- 19 Sep 2017 New trial record
- 15 Sep 2017 According to a Biohaven Pharmaceutical Holding Company media release, the company has a clinical trial collaboration with the Alzheimer's Disease Cooperative Study (ADCS) for the condut of this trial.